Streetbeat News

Analyst Ratings

VTEX

Zacks Under $10 Newsletter has mentioned VTEX as a buy recommendation.

Portfolio Pulse from Happy Mohamed

August 22, 2023 | 2:43 pm

DQ

IMMR

RELL

SURG

TSRI

Benzinga Insights has identified five value stocks in the technology sector based on quantified analysis. These include Daqo New Energy (NYSE:DQ), Surgepays (NASDAQ:SURG), TSR (NASDAQ:TSRI), Richardson Electronics (NASDAQ:RELL), and Immersion (NASDAQ:IMMR). The companies have been selected due to their low P/E multiples, indicating they may be undervalued. Recent earnings per share and dividend yield data for each company is also provided.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 2:41 pm

FN

Fabrinet (NYSE:FN) reported better-than-expected Q4 earnings of $1.86 per share, beating the consensus estimate of $1.80. The company also reported quarterly sales of $655.87 million, surpassing the estimate of $641.41 million. Fabrinet issued Q1 earnings guidance between $1.83 and $1.90 per share, with revenue anticipated to be between $650 million and $670 million. Following the earnings announcement, analysts from Needham, Lake Street, and Northland Capital Markets raised their price targets on Fabrinet.

Portfolio Pulse from Lisa Levin

August 22, 2023 | 2:38 pm

ASXC

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Asensus Surgical (AMEX:ASXC) and maintained a $1 price target.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 2:37 pm

FN

FULC

HAS

HKD

VFS

Several stocks recorded gains in the recent trading session. Fulcrum Therapeutics shares gained 42.8% after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease. VinFast Auto gained 36.5% amid volatility following its recent Nasdaq debut. Fabrinet jumped 25% after reporting better-than-expected Q4 results and issuing guidance. AMTD Digital gained 13.8% after announcing a $30 million share repurchase program. Hasbro rose 7.4% after B of A Securities maintained a Buy rating and raised the price target.

Portfolio Pulse from Lisa Levin

August 22, 2023 | 2:29 pm

ROIV

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Roivant Sciences (NASDAQ:ROIV) and maintained a $15 price target.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 2:24 pm

PCVX

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Vaxcyte (NASDAQ:PCVX) and maintained a $70 price target.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 2:23 pm

MRK

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a price target of $135.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 2:22 pm

LLY

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (NYSE:LLY) and maintained a price target of $630.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 2:21 pm

C

A significant bearish stance has been taken on Citigroup (NYSE:C) as indicated by unusual options activity. Benzinga's options scanner spotted 11 uncommon options trades for Citigroup, with the sentiment of these big-money traders being split between 36% bullish and 63% bearish. Whales have been targeting a price range from $23.0 to $65.0 for Citigroup over the last 3 months. Oppenheimer has maintained their Outperform rating on Citigroup, with a price target of $85.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 2:16 pm